Skin disorder
Therapeutic area
Dermatology
Rare disease
No
- Definition
- Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Skin disorder
- Therapeutic area
- Dermatology
- skin disorder
- cutaneous disorder
- disease of zone of skin
- disease or disorder of zone of skin
- disorder of skin
- disorder of zone of skin
- skin diseases and manifestations
- skin disorder
- zone of skin disease
- zone of skin disease or disorder
- dermatosis
- genodermatosis
- All therapeutic areas
- Dermatology
- Severity
- Unknown
- MONDO ID
- MONDO:0005093
- Parent condition
- MONDO:0002051
Related records
Broader conditions (4)
- Disease
- Disease by body system or component
- Human disease
- Integumentary system disorder
Narrower conditions (1,453)
- 13q12.3 microdeletion syndrome
- 2-hydroxyethyl methacrylate sensitization
- 22q-related schwannomatosis
- Absence of fingerprints-congenital milia syndrome
- Acanthokeratolytic verrucous nevus
- Acantholytic acanthoma
- Acantholytic squamous cell skin carcinoma
- Acanthoma
- Acanthosis nigricans
- Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome
- Achenbach syndrome
- Ackerman syndrome
- Acne
- Acne inversa, familial, 1
- Acne inversa, familial, 2
- Acne inversa, familial, 3
- Acne keloid
- Acneiform dermatitis
- Acquired angioedema
- Acquired angioedema type 1
Trials (606)
- (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
- A 28-day Clinical Study on Facial Skin Rejuvenation
- A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses
- A Clinical Study Evaluating the Efficacy and Tolerability of a Topical Facial Treatment For Facial Rejuvenation
- A Clinical Study on Pre-operative Intervention With Products During Aesthetic Medicine
- A Clinical Study on the Improvement of Skin and Living Conditions After Drinking Rosa Roxburghii and Pomegranate Drinks
- A Clinical Study on the Improvement of Sleep Quality, Skin Condition and Life Status After Taking Sleep Aid Drinks
- A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato
- A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone
- A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease
- A Controlled Clinical Study of 2 Different Moisturizers for the Relief of Dry Skin
- A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines
- A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis
- A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Nutritional Supplement Lumenato and Its Impact on Skin Parameters in Healthy Female Subjects
- A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions
- A Herbal Compound for Psoriasis
- A Human In-vivo Model for the Detection of Inflammatory and Nociceptive Biomarkers
- A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp
- A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp
Approved drugs (28)
- Alclometasone dipropionate
- Betamethasone dipropionate
- Betamethasone valerate
- Brimonidine tartrate
- Clobetasol propionate
- Delafloxacin meglumine
- Desonide
- Desoximetasone
- Diflorasone diacetate
- Fluocinolone acetonide
- Fluocinonide
- Flurandrenolide
- Fluticasone propionate
- Halcinonide
- Halobetasol propionate
- Hydrocortisone
- Hydrocortisone acetate
- Hydrocortisone butyrate
- Hydrocortisone probutate
- Hydroxyzine pamoate
Drugs in development (59)
- Adapalene Phase 1
- Allantoin Phase 2
- Aztreonam Phase 3
- Bizelesin Phase 1
- Calcipotriene Phase 2
- Carboplatin Phase 1
- Cefazolin Phase 3
- Ceftazidime Phase 3
- Ceftobiprole medocaril sodium Phase 3
- Cephalexin Phase 3
- Cholecalciferol Phase 1
- Clindamycin Phase 3
- Daptomycin Phase 3
- Dexpanthenol Phase 3
- Diltiazem hydrochloride Phase 1
- Donepezil Phase 1
- Doxycycline Phase 2
- Dupilumab Early phase 1
- Edodekin alfa Phase 1
- Floxacillin Phase 3
Other linked drugs (9)
- Bilastine
- Desloratadine
- Diphencyprone
- Epinastine hydrochloride
- Erythromycin
- Fexofenadine hydrochloride
- Olopatadine hydrochloride
- Petrolatum
- Sulforaphane